Preterm Birth: Clinical Trials

4 trials for Preterm Birth, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 4
Phase 32Recruiting 2
Phase 11Recruiting 1

Follow Preterm Birth: new trials by email Literature Review of Preterm Birth trials Research Report on Preterm Birth

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants
Nicotinamide Riboside (NR), Placebo - Preterm Birth, Inadequate Milk Production
Phase 2 / Phase 3RecruitingUniversity of California, Davis402026-08-192026-09-14
Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial
Xylitol Chewing gum, Sorbitol chewing gum - Preterm Birth, Low Birthweight Neonate
Phase 2 / Phase 3RecruitingUniversity of Washington60002026-03-262026-09-10
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
Daily aspirin (ASA), Split dose aspirin (ASA) - Preterm Birth, Preeclampsia
Phase 1 / Phase 2RecruitingThomas Jefferson University4002025-06-262025-07-17
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
Sulfasalazine - Preterm Birth
Phase 2RecruitingRutgers, The State University of New Jersey502023-03-012026-07-09

Narrower conditions

Premature Birth (4)  ·  Gingivitis (1)  ·  Learning Disabilities (1)  ·  Periodontal Diseases (1)  ·  Periodontitis (1)  ·  Pre-Eclampsia (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (4)  ·  Obstetric Labor Complications (4)  ·  Obstetric Labor, Premature (4)  ·  Pregnancy Complications (4)  ·  Urogenital Diseases (4)  ·  Communication Disorders (1)  ·  Gingival Diseases (1)  ·  Hypertension, Pregnancy-Induced (1)  ·  Infections (1)  ·  Mental Disorders (1)  ·  Mouth Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurodevelopmental Disorders (1)  ·  Neurologic Manifestations (1)

Interventions

Sulfasalazine (1)  ·  nicotinamide-beta-riboside (1)

Sponsors

Rutgers, The State University of New Jersey (1)  ·  Thomas Jefferson University (1)  ·  University of California, Davis (1)  ·  University of Washington (1)

Countries

United States (3)  ·  Malawi (1)

Top investigators

Emily Rosenfeld, DO (1)  ·  Greg Valentine (1)

Results publications

PMID 20008425, PMID 27721479, PMID 29469929, PMID 29599478, PMID 29992272, PMID 30673618, PMID 30797625, PMID 31035376, PMID 31278280, PMID 32421208, PMID 33769844, PMID 34084879, PMID 34292494, PMID 34871486, PMID 37478182, PMID 38987585, PMID 4060272, PMID 42843881

NIH funding

R01HD112076 (1), R01HD119029 (1)